FINWIRES · TerminalLIVE
FINWIRES

Take-Two Interactive Software Guidance and GTA VI Timing Are Key Focus Ahead of Earnings, Wedbush Says

By

Take-Two Interactive Software (TTWO) is heading into a key "go/no-go" earnings moment, with investor attention set to center on fiscal guidance and confirmation of the Grand Theft Auto VI release schedule ahead of the May 21 call, Wedbush Securities said in a Friday note.

The analyst said the update will be critical in determining whether GTA VI remains on track for its Nov. 19 launch, noting Rockstar's historical tendency to signal major delays roughly six months in advance, making this call a pivotal checkpoint for expectations.

Wedbush expects fiscal Q4 results to come in at the high end of guidance, modeling net bookings of about $1.56 billion versus guidance of $1.51 to $1.56 billion and earnings per share of $0.56 at the top of the $0.46 to $0.56 range, supported in part by strength in mobile gaming, according to the report.

Looking ahead, Wedbush said fiscal 2027 guidance will be the most important driver of sentiment, with estimates at roughly $9.40 billion in bookings and $6.40 in EPS versus consensus of about $9.33 billion and $7.97, as investors look for clarity on GTA VI scale, mobile momentum, and the timing of launch contributions.

Wedbush maintained its outperform rating on the stock with a price target of $300.

Price: $243.11, Change: $+0.70, Percent Change: +0.29%

Related Articles

Wire

Aardvark Therapeutics' Investigational New Drug Application for ARD-101 Put on Clinical Hold by FDA

Aardvark Therapeutics (AARD) said late Thursday the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101 to treat hyperphagia associated with Prader-Willi Syndrome.The hold applies to all ongoing clinical studies under the IND, the company said, adding that it is in discussions with the FDA for resolution of the clinical hold and to fix a path forward for the drug candidate.The company also plans to unblind clinical data from the HERO and OLE trials to assess the totality of efficacy and safety data, according to the company.The company said it had $91.2 million in cash and cash equivalents as of March 31, adequate to fund operations into mid-2027.

$AARD
Wire

Sky Harbour Q1 Loss Narrows, Revenue Rises; Shares Fall After Hours

Sky Harbour Group (SKYH) reported a Q1 loss late Thursday of $0.16 per diluted share, narrowing from a loss of $0.19 a year earlier.Analysts polled by FactSet expected a loss of $0.13.Revenue in the three months ended March 31 rose to $8.73 million from $5.59 million a year earlier.Analysts surveyed by FactSet expected $9.8 million.Sky Harbour shares fell 4.9% in after-hours trading.

$SKYH
Wire

KinderCare Learning Q1 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours

KinderCare Learning (KLC) reported Q1 adjusted earnings late Thursday of $0.04 per diluted share, down from $0.23 a year earlier.Analysts surveyed by FactSet expected a loss of $0.01.Revenue in the three months ended April 4 rose to $672.5 million from $668.2 million a year earlier.Analysts surveyed by FactSet expected $669.1 million.The company boosted full-year adjusted EPS guidance to $0.15 to $0.25 from the previous forecast of $0.10 to $0.20. It affirmed the revenue outlook of $2.7 billion to $2.75 billion.Analysts expect EPS of $0.15 on revenue of $2.71 billion.KinderCare shares fell 6.2% in after-hours trading.

$KLC
Take-Two Interactive Software Guidance and GTA VI Timing Are Key Focus Ahead of Earnings, Wedbush Says | FINWIRES